2 members of Congress have disclosed 4 trades in SOLAZYME INC (SZYM) since 2014: 2 purchases worth about $16.00K and 2 sales worth about $16.00K. The most active was John Garamendi, with 2 trades. The latest trade was made on Apr 21, 2017.
| # | Member | Trades | Buys | Sells | Bought (est.) | Sold (est.) | Net | Buys vs SPY | First Traded | Last Traded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | John GaramendiD-CA | 2 | 1 | 1 | $8.00K | $8.00K | $0.00 | – | Jan 8, 2016 | Apr 21, 2017 |
| 2 | Suzan K. DelBeneD-WA | 2 | 1 | 1 | $8.00K | $8.00K | $0.00 | – | May 12, 2014 | Nov 6, 2014 |
| Owner | Type | Filing | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| John GaramendiD-CA | SZYMSolazyme, Inc. | Joint | Buy | $1K–$15K | Jan 8, 2016 | Jul 18, 2017 | 557d late | – | – | |
| John GaramendiD-CA | SZYMSolazyme, Inc. | Spouse | Sell | $1K–$15K | Apr 21, 2017 | Jul 18, 2017 | 88d late | – | – | |
| Suzan K. DelBeneD-WA | SZYMSolazyme, Inc. | Joint | Sell | $1K–$15K | Nov 6, 2014 | Dec 11, 2014 | 35d | – | – | |
| Suzan K. DelBeneD-WA | SZYMSolazyme, Inc. | Joint | Buy | $1K–$15K | May 12, 2014 | Jun 12, 2014 | 31d | – | – |
Tip. Hover a row for the filing’s full asset text and comments; the PDF link opens the report itself.
2 members of Congress have disclosed 4 trades in SOLAZYME INC (SZYM) since 2014: 2 purchases worth about $16.00K and 2 sales worth about $16.00K. The most active was John Garamendi, with 2 trades. The latest trade was made on Apr 21, 2017. Most active: John Garamendi (2), Suzan K. DelBene (2).
Since 2014 they have disclosed 2 purchases and 2 sales; by the midpoints of the disclosed ranges, about $16.00K bought and $16.00K sold, a net purchase of $0.00.
Members of Congress report each trade over $1,000 within 45 days under the STOCK Act, with the amount as a range. The chart marks the days members traded SZYM on its price, against the S&P 500 over the same days.
Members of Congress disclose trades as dollar ranges, up to 45 days after the trade and sometimes later. Volumes use the midpoints of those ranges and are estimates; portfolio figures are a model built from the disclosed trades, not the members’ actual accounts. Not investment advice.